InsidersTradesSigma
Follow the 金域医学 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 金域医学 has published 3 public disclosures. Market capitalisation: €12.9bn. The latest transaction was reported on 15 July 2024 (Purchase). Among the most active insiders: 郝必喜. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
金域医学 is a company specializing in medical diagnostic services and laboratory testing in China. It provides innovative and high-quality health solutions for healthcare professionals.